KR890001544A - Pharmaceutical composition with brain cell protection - Google Patents

Pharmaceutical composition with brain cell protection Download PDF

Info

Publication number
KR890001544A
KR890001544A KR1019870006905A KR870006905A KR890001544A KR 890001544 A KR890001544 A KR 890001544A KR 1019870006905 A KR1019870006905 A KR 1019870006905A KR 870006905 A KR870006905 A KR 870006905A KR 890001544 A KR890001544 A KR 890001544A
Authority
KR
South Korea
Prior art keywords
pharmaceutical composition
active ingredient
brain cell
cell protection
oxazolidin
Prior art date
Application number
KR1019870006905A
Other languages
Korean (ko)
Other versions
KR950009092B1 (en
Inventor
고구레규야
미쓰오 마사끼
Original Assignee
우시야마 게이조오
닛뽕 케미화 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 우시야마 게이조오, 닛뽕 케미화 가부시끼가이샤 filed Critical 우시야마 게이조오
Priority to KR1019870006905A priority Critical patent/KR950009092B1/en
Publication of KR890001544A publication Critical patent/KR890001544A/en
Application granted granted Critical
Publication of KR950009092B1 publication Critical patent/KR950009092B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

내용 없음No content

Description

뇌세포 보호작용을 가지는 의약 조성물Pharmaceutical composition with brain cell protection

본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음Since this is an open matter, no full text was included.

Claims (4)

의약 활성성분으로서 일반식(I)의 1,3-옥사졸리딘-2-온-유도체를 함유함을 특징으로 하는 뇌세포 보호작용을 가지는 의약 조성물.A pharmaceutical composition having a protective effect on brain cells, characterized by containing a 1,3-oxazolidin-2-one-derivative of general formula (I) as a pharmaceutically active ingredient. 상기 식에서, R은 3 내지 8의 탄소원자를 가지는 직쇄 또는 측쇄 알킬기이고, X는 수소원자, 할로겐원자, 저급알킬 또는 알콕시기이고, n은 4,5 또는 6이다.Wherein R is a straight or branched alkyl group having 3 to 8 carbon atoms, X is a hydrogen atom, a halogen atom, a lower alkyl or an alkoxy group, and n is 4, 5 or 6; 제1항에 있어서, 활성 성분이(4S,5R)-4-(2-메틸프로필)-5-페닐-3-(3-피페리디노프로필)-1,3-옥사졸리딘-2-온임을 특징으로 하는 의약 조성물.The compound according to claim 1, wherein the active ingredient is (4S, 5R) -4- (2-methylpropyl) -5-phenyl-3- (3-piperidinopropyl) -1,3-oxazolidin-2-one Pharmaceutical composition characterized in that. 제1항에 있어서, 활성성분이(4S,5R)-4-(2-메틸프로필)-3[3-(퍼히드로아제핀-1-일)프로필]-5-페닐-1,3-옥사졸리딘-2-온임을 특징으로 하는 의약 조성물.The compound according to claim 1, wherein the active ingredient is (4S, 5R) -4- (2-methylpropyl) -3 [3- (perhydroazin-1-yl) propyl] -5-phenyl-1,3-oxa Pharmaceutical composition characterized in that it is zolidin-2-one. 제1항에 있어서, 조성물이 경구 또는 비경구 투약제의 형태임을 특징으로 하는 의약 조성물.The pharmaceutical composition according to claim 1, wherein the composition is in the form of an oral or parenteral dosage form. ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.※ Note: The disclosure is based on the initial application.
KR1019870006905A 1987-07-01 1987-07-01 Pharmaceutical compositions for protection of brain cells KR950009092B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019870006905A KR950009092B1 (en) 1987-07-01 1987-07-01 Pharmaceutical compositions for protection of brain cells

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019870006905A KR950009092B1 (en) 1987-07-01 1987-07-01 Pharmaceutical compositions for protection of brain cells

Publications (2)

Publication Number Publication Date
KR890001544A true KR890001544A (en) 1989-03-27
KR950009092B1 KR950009092B1 (en) 1995-08-14

Family

ID=19262595

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019870006905A KR950009092B1 (en) 1987-07-01 1987-07-01 Pharmaceutical compositions for protection of brain cells

Country Status (1)

Country Link
KR (1) KR950009092B1 (en)

Also Published As

Publication number Publication date
KR950009092B1 (en) 1995-08-14

Similar Documents

Publication Publication Date Title
KR910011895A (en) drugs
KR880006193A (en) Piperidine Compounds and Their Preparation and Uses
IE790064L (en) Tetrahydropyridinylindoles
KR890012967A (en) Piperidine derivatives
ES8506635A1 (en) Morphinane derivatives, their preparation and pharmaceutical preparations containing them.
KR960007592A (en) New pyrrolocarbazole
KR900001693A (en) Azacyclic Compounds, Methods for Preparing the Same, and Uses thereof
KR920016089A (en) Treatment of Type I Diabetes
ATE33831T1 (en) ANALGESIC 5-HYDROXYTRYPTOPHAN DERIVATIVES.
KR860700250A (en) New amidine compounds
KR890006639A (en) Benzothiazine dioxide derivatives
KR870007164A (en) Monosulpactam
KR840006985A (en) N-substituted flavone-8-carboxamide derivatives and preparation method thereof
KR910005859A (en) Antitumor agents
KR890001544A (en) Pharmaceutical composition with brain cell protection
KR900016178A (en) 2-substituted N, N'-ditrimethoxybenzoyl piperazine, preparation method thereof and therapeutic composition containing the same
KR900007415A (en) Amnesiac improver
KR890009901A (en) 3-hydroxy-2- (4-methoxyphenyl) -5- (2-methylaminoethyl) -2,3-dihydro-5H-1,5-benzothiazepin-4-one derivative, its preparation and The use to the treatment
KR880002528A (en) Pharmaceutical composition with brain cell protection
KR900006316A (en) Benzo heterocyclic compound and preparation method thereof
KR890008129A (en) New compounds
KR910005860A (en) Anti Liver Disease Composition
KR900004342A (en) Use of 6-halo-4-quinolone compounds and pharmaceutical compositions thereof for the manufacture of a medicament for the treatment of tumatoid arthritis
KR880013938A (en) Active compounds
KR870001153A (en) Pharmaceutical composition containing diphenoxyethylamine derivative and its production method

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 19990227

Year of fee payment: 5

LAPS Lapse due to unpaid annual fee